The 6-in-1 Part 2 Vaccine Study

 

The 6-in-1 Part 2 Vaccine Study

 

Recruiting now for The 6-in-1 Part 2 Vaccine Study. Oxford Vaccine Group, University of Oxford would like to invite your child to take part in a study to help guide future changes to the UK immunisation schedule. We want to enroll healthy children, who have not yet received their 12-month routine vaccinations.

POInT

The Oxford Vaccine Group is recruiting infants aged 4 – 7 months to a type 1 diabetes prevention trial. POInT (Primary Oral Insulin Trial) is recruiting infants who were screened for diabetes at birth through the INGR1D Study and have been found to be at high risk for developing diabetes.